Literature DB >> 9115708

Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.

J Bujia1, C Kim, P Ostos-Aumente, J Lopez-Villarejo, E Kastenbauer.   

Abstract

Middle ear cholesteatoma epithelium is a rich source of interleukin-1-alpha (IL-1-alpha), being involved in both keratinocyte hyperproliferation and bone destruction. IL-1-alpha exerts its effects by binding to two distinct IL-1 receptors (IL-1-R). In this study, we have examined the expression of IL-1-R type II (IL-1-R-II) in cholesteatoma samples and have quantified these levels with computer-assisted image analysis. Normal aural skin was used as control. Immunostaining demonstrated the presence of IL-1-R-II in both epidermis and cholesteatoma keratinocytes. The receptors were 3 times higher than those in normal epidermis. The presence of IL-1-alpha in cholesteatoma epithelium coupled with the induced expression of IL-1-R-II indicates the existence of a highly regulated system of autocrine stimulation of cholesteatoma keratinocytes by IL-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115708     DOI: 10.1007/bf02630748

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

Review 1.  Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations.

Authors:  T S Kupper
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Regulation of interleukin 1 and its receptor in human keratinocytes.

Authors:  R A Blanton; T S Kupper; J K McDougall; S Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

4.  Interleukin 1 is present in normal human epidermis.

Authors:  C Hauser; J H Saurat; A Schmitt; F Jaunin; J M Dayer
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

5.  Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma.

Authors:  J M Ahn; C C Huang; M Abramson
Journal:  Otolaryngol Head Neck Surg       Date:  1990-10       Impact factor: 3.497

6.  Membrane and cytosolic interleukin-1 alpha and beta in normal human epidermal cells: variability of epitope exposure in immunohistochemistry.

Authors:  H S Anttila; S Reitamo; P Erkko; A Miettinen; L Didierjean; J H Saurat
Journal:  J Invest Dermatol       Date:  1990-07       Impact factor: 8.551

7.  Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.

Authors:  R W Groves; L Sherman; H Mizutani; S K Dower; T S Kupper
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

8.  A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein.

Authors:  H J Ristow
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 9.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

Review 10.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.

Authors:  C A Dinarello; R C Thompson
Journal:  Immunol Today       Date:  1991-11
View more
  2 in total

1.  Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Authors:  Miroslaw J Szczepanski; Michal Luczak; Ewa Olszewska; Marta Molinska-Glura; Mariola Zagor; Antoni Krzeski; Henryk Skarzynski; Jan Misiak; Karolina Dzaman; Mikolaj Bilusiak; Tomasz Kopec; Malgorzata Leszczynska; Henryk Witmanowski; Theresa L Whiteside
Journal:  J Mol Med (Berl)       Date:  2014-11-12       Impact factor: 4.599

Review 2.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.